RT journal article T1 Oligodendroglia vulnerability in the human dorsal striatum in Parkinson’s disease A1 Barba Reyes, Juan Manuel A1 Harder, Lisbeth A1 Marco Salas, Sergio A1 Jaisa-aad, Methasit A1 Muñoz-Castro, Clara A1 Garma, Leonardo D. A1 Rafati, Nima A1 Nilsson, Mats A1 Hyman, Bradley T. A1 Serrano Pozo, Alberto A1 Muñoz Manchado, Ana Belén A2 Neurociencias K1 Myelin K1 Neurodegeneration K1 Oligodendrocyte K1 Sc-RNA-seq K1 Spatial transcriptomics K1 Striatum AB Oligodendroglia are the responsible cells for myelination in the central nervous system and their involvement in Parkinson’s disease (PD) is poorly understood. We performed sn-RNA-seq and image-based spatial transcriptomics of human caudate nucleus and putamen (dorsal striatum) from PD and control brain donors to elucidate the diversity of oligodendroglia and how they are affected by the disease. We profiled a total of ~ 200.000 oligodendroglial nuclei, defining 15 subclasses, from precursor to mature cells, 4 of which are disease-associated. These PD-specific populations are characterized by the overexpression of heat shock proteins, as well as distinct expression signatures related to immune responses, myelination alterations, and disrupted cell signaling pathways. We have also identified impairments in cell communication and oligodendrocyte development, evidenced by changes in neurotransmitter receptors expression and cell adhesion molecules. In addition, we observed significant disruptions in oligodendrocyte development, with aberrant differentiation trajectories and shifts in cell proportions, particularly in the transition from mature oligodendrocytes to disease-associated states. Quantitative immunohistochemical analysis revealed decreased myelin levels in the PD striatum, which correlated with transcriptomic alterations. Furthermore, spatial transcriptomics mapping revealed the distinct localization of disease-associated populations within the striatum, with evidence of impaired myelin integrity. Thus, we uncover oligodendroglia as a critical cell type in PD and a potential new therapeutic target for myelin-based interventions. PB Springer Science SN 1432-0533 YR 2025 FD 2025 LK http://hdl.handle.net/10498/38174 UL http://hdl.handle.net/10498/38174 LA eng DS Repositorio Institucional de la Universidad de Cádiz RD 18-nov-2026